The DARONRIX brand, founded in 1999 (Belgium), from 1722 sister brands and 17478 competing brands. The DARONRIX brand is owned by GSK PLC, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. The sector of DARONRIX is Drug Manufacturers.